৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
Treatment of partial‑onset seizures in adult patients.
Cenobamate is a positive GABA‑A modulator and inhibits voltage‑gated sodium channels.
Increases threshold for action potential generation and reduces number of action potentials.
Dual complementary mechanisms contribute to strong anti‑seizure activity.
Can be taken with or without food.
Initial dose: Week 1–2: 12.5 mg once daily.
Titration regimen:
Week 3–4: 25 mg once daily
Week 5–6: 50 mg once daily
Week 7–8: 100 mg once daily
Week 9–10: 150 mg once daily
Maintenance dose: Week 11 onward: 200 mg once daily.
Maximum dose: May increase by 50 mg every 2 weeks up to 400 mg daily if needed.
Phenytoin: Reduce dose up to 50%.
Phenobarbital, Clobazam: Reduce dose as needed.
Lamotrigine, Carbamazepine, CYP2B6/3A substrates: Increase dose as needed.
CYP2C19 substrates: Reduce dose.
Oral contraceptives: Effectiveness may be reduced → use alternative birth control.
Hypersensitivity to Cenobamate or excipients.
Familial Short QT syndrome.
Common: Somnolence, fatigue, dizziness, nausea, constipation, double vision, decreased appetite, diarrhea, weakness.
Rare: Severe allergic reaction.
No adequate studies in pregnant women. May cause fetal harm. Use only if benefit outweighs risk.
Unknown if excreted in breast milk.
Risks: Multiorgan hypersensitivity, QT shortening, suicidal thoughts.
Monitor somnolence, fatigue, mood changes.
Advise patients not to drive or operate machinery until stable.
Gradual withdrawal recommended to avoid seizure recurrence.
Pediatric: Not established (<18 years).
Geriatric: Start at low dose.
Renal impairment: Max 300 mg/day; avoid in end‑stage renal disease or dialysis.
Hepatic impairment: Use with caution in mild/moderate; avoid in severe cases.
Discontinue and provide supportive treatment until toxicity resolves.






Cenobamate is an antiepileptic (anticonvulsant) medicine used to treat partial-onset (focal) seizures in adults. It works through a dual mechanism: enhancing inhibitory GABA activity and reducing excitatory sodium channel activity in the brain, helping to stabilize abnormal electrical activity.
Cenobamate is used in epilepsy patients to reduce seizure frequency and severity, especially in treatment-resistant cases. It helps improve seizure control and overall quality of life in people with chronic epilepsy.

